Probiotic Plus: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Probiotic Plus
Largest movements
- Cash -€2,713
down €2,713 (-90.8%), from €2,989 to €276
mainly Net result for the year (-€5,305)
- Receivables within one year -€50
down €50 (-48.6%), from €103 to €53
of which Other amounts receivable: -€50
- Profit (loss) carried forward -€5,305
down €5,305 (-9.3%), from -€56,951 to -€62,256
- Other debts +€2,542
up €2,542 (+25.3%), from €10,043 to €12,585
- Gross operating margin -€8,504
down €8,504, from €4,547 to -€3,958
- Financial income -€1,251
down €1,251 (-100.0%), from €1,251 to €0
- Other operating charges -€1,234
down €1,234 (-69.4%), from €1,778 to €544
- Financial charges +€72
up €72 (+9.8%), from €732 to €804
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €3,092 | €329 | -€2,763 | -89.4% |
| Current assets | 29/58 | €3,092 | €329 | -€2,763 | -89.4% |
| Stocks and contracts in progress | 3 | €0 | - | = | |
| Stocks | 30/36 | €0 | - | = | |
| Amounts receivable within one year | 40/41 | €103 | €53 | -€50 | -48.6% |
| Trade receivables | 40 | €0 | - | = | |
| Other amounts receivable | 41 | €103 | €53 | -€50 | -48.6% |
| Cash at bank and in hand | 54/58 | €2,989 | €276 | -€2,713 | -90.8% |
| Total equity and liabilities | 10/49 | €3,092 | €329 | -€2,763 | -89.4% |
| Equity | 10/15 | -€6,951 | -€12,256 | -€5,305 | -76.3% |
| Contributions | 10/11 | €50,000 | €50,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€56,951 | -€62,256 | -€5,305 | -9.3% |
| Amounts payable | 17/49 | €10,043 | €12,585 | +€2,542 | +25.3% |
| Amounts payable within one year | 42/48 | €10,043 | €12,585 | +€2,542 | +25.3% |
| Trade debts | 44 | €0 | - | = | |
| Suppliers | 440/4 | €0 | - | = | |
| Taxes, remuneration and social security | 45 | €0 | - | = | |
| Taxes | 450/3 | €0 | - | = | |
| Other amounts payable | 47/48 | €10,043 | €12,585 | +€2,542 | +25.3% |
| Other operating charges | 640/8 | €1,778 | €544 | -€1,234 | -69.4% |
| Gross operating margin | 9900 | €4,547 | -€3,958 | -€8,504 | |
| Operating profit (loss) | 9901 | €2,769 | -€4,502 | -€7,270 | |
| Financial income | 75/76B | €1,251 | €0 | -€1,251 | -100.0% |
| Recurring financial income | 75 | €1,251 | €0 | -€1,251 | -100.0% |
| Financial charges | 65/66B | €732 | €804 | +€72 | +9.8% |
| Recurring financial charges | 65 | €732 | €804 | +€72 | +9.8% |
| Profit (loss) for the period before taxes | 9903 | €3,288 | -€5,305 | -€8,593 | |
| Profit (loss) for the period | 9904 | €3,288 | -€5,305 | -€8,593 | |
| Profit (loss) for the period to be appropriated | 9905 | €3,288 | -€5,305 | -€8,593 |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 30 September 2026 via checked.be.